⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SRPT News
Sarepta Therapeutics,, Inc. Common Stock
Form 8-K
sec.gov
SRPT
Form 8-K
sec.gov
SRPT
Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments
businesswire.com
SRPT
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
businesswire.com
SRPT
MIPI Alliance發表UniPro v3.0和M-PHY v6.0，協助提升行動裝置、PC和汽車領域邊緣AI的JEDEC UFS效能
businesswire.com
GOOGL
QCOM
TXN
MU
INTC
AAPL
MSFT
NVDA
AMZN
ADI
NXPI
STM
ON
AMD
MRVL
AVGO
MCHP
WDC
SE
SMTC
SNPS
AMKR
ALGN
ASML
CDNS
CHKP
CRUS
DLTR
ENPH
ERIC
FSLR
GILD
HPE
IBM
INFY
INTU
KEYS
KHC
LRCX
LULU
MDT
MELI
MNST
MRNA
MSI
NFLX
NTAP
ORCL
PAYX
PEP
PPC
PYPL
REGN
ROST
SBUX
SIRI
SNOW
SRPT
SWKS
TCOM
TDS
TECK
TER
TGT
TMO
TSLA
TTWO
ULTA
VRSK
VRTX
WEC
XEL
XRAY
ZBRA
ZM
ZS
Sarepta Therapeutics to Present at the TD Cowen 46 th Annual Health Care Conference
businesswire.com
SRPT
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
Global Oligonucleotide Therapeutics Market Set to Surge to USD 17.70 Billion by 2030 | MarketsandMarkets™
globenewswire.com
BIIB
ALNY
SRPT
Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2025 Financial Results
businesswire.com
SRPT
Global Gene Therapy and CRISPR Market Shows Billion Dollar Growth with Novartis Zolgensma 1.2 Billion Sarepta Elevidys 611 Million and Emerging CRISPR Collaborations 20 Million
globenewswire.com
NVS
SRPT